IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus

Antiretroviral therapy (ART) suppresses HIV-1 viremia and prevents progression to AIDS. Nonetheless, chronic inflammation is a common problem for people living with HIV-1 on ART. One possible cause of inflammation is ongoing transcription from HIV-1 proviruses, whether or not the sequences are competent for replication. Previous work has shown that intron-containing RNA expressed from the HIV-1 provirus in primary human blood cells, including CD4+ T cells, macrophages, and dendritic cells, activates type 1 interferon. This activation required HIV-1 rev and was blocked by the XPO1 (CRM1)-inhibitor leptomycin. To identify the innate immune receptor required for detection of intron-containing RNA expressed from the HIV-1 provirus, a loss-of-function screen was performed with shRNA-expressing lentivectors targeting twenty-one candidate genes in human monocyte derived dendritic cells. Among the candidate genes tested, only knockdown of XPO1 (CRM1), IFIH1 (MDA5), or MAVS prevented activation of the IFN-stimulated gene ISG15. The importance of IFIH1 protein was demonstrated by rescue of the knockdown with non-targetable IFIH1 coding sequence. Inhibition of HIV-1-induced ISG15 by the IFIH1-specific Nipah virus V protein, and by IFIH1-transdominant inhibitory CARD-deletion or phosphomimetic point mutations, indicates that IFIH1 filament formation, dephosphorylation, and association with MAVS, are all required for innate immune activation in response to HIV-1 transduction. Since both IFIH1 and DDX58 (RIG-I) signal via MAVS, the specificity of HIV-1 RNA detection by IFIH1 was demonstrated by the fact that DDX58 knockdown had no effect on activation. RNA-Seq showed that IFIH1-knockdown in dendritic cells globally disrupted the induction of IFN-stimulated genes. Finally, specific enrichment of unspliced HIV-1 RNA by IFIH1 was revealed by formaldehyde crosslinking immunoprecipitation (f-CLIP). These results demonstrate that IFIH1 is required for innate immune activation by intron-containing RNA from the HIV-1 provirus, and potentially contributes to chronic inflammation in people living with HIV-1.

[1]  Michael T. Lu,et al.  Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. , 2023, The New England journal of medicine.

[2]  R. Siliciano,et al.  The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy , 2023, The Journal of clinical investigation.

[3]  P. Edlefsen,et al.  Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation , 2023, medRxiv : the preprint server for health sciences.

[4]  L. James,et al.  IP6‐stabilised HIV capsids evade cGAS/STING‐mediated host immune sensing , 2023, EMBO reports.

[5]  J. Clements,et al.  Monocyte-derived macrophages contain persistent latent HIV reservoirs , 2023, Nature Microbiology.

[6]  Xu G. Yu,et al.  Cooperation between cGAS and RIG-I sensing pathways enables improved innate recognition of HIV-1 by myeloid dendritic cells in elite controllers , 2022, Frontiers in Immunology.

[7]  B. Hahn,et al.  Evasion of cGAS and TRIM5 defines pandemic HIV , 2022, Nature Microbiology.

[8]  S. Valente,et al.  The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A. , 2021, The Journal of infectious diseases.

[9]  N. Lin,et al.  HIV-1 transcription but not intact provirus levels are associated with systemic inflammation. , 2020, The Journal of infectious diseases.

[10]  G. Hartmann,et al.  Absence of cGAS-mediated type I IFN responses in HIV-1–infected T cells , 2020, Proceedings of the National Academy of Sciences.

[11]  Matthew D. Edwards,et al.  Determination of RNA structural diversity and its role in HIV-1 RNA splicing , 2020, Nature.

[12]  Lawrence M. Lifshitz,et al.  HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells , 2019, Nature Immunology.

[13]  A. Vos,et al.  Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. , 2019, The New England journal of medicine.

[14]  M. Peeters,et al.  Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. , 2019, The New England journal of medicine.

[15]  Onur Yukselen,et al.  DolphinNext: a distributed data processing platform for high throughput genomics , 2019, BMC Genomics.

[16]  G. Melikyan,et al.  A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing , 2019, Journal of Virology.

[17]  B. Walker Faculty Opinions recommendation of A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[18]  J. Luban,et al.  Cyclophilin A protects HIV-1 from restriction by human TRIM5α , 2019, Nature Microbiology.

[19]  Abraham J. Kandathil,et al.  No recovery of replication-competent HIV-1 from human liver macrophages , 2018, The Journal of clinical investigation.

[20]  A. Belkina,et al.  HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction , 2018, Nature Communications.

[21]  A. Aderem,et al.  Reshaping of the Dendritic Cell Chromatin Landscape and Interferon Pathways during HIV Infection. , 2018, Cell host & microbe.

[22]  Lloyd M. Smith,et al.  Elucidating the in vivo interactome of HIV-1 RNA by hybridization capture and mass spectrometry , 2017, Scientific Reports.

[23]  J. Luban,et al.  Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines , 2017, Nature Communications.

[24]  R. El-Diwany,et al.  Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals , 2017, AIDS.

[25]  J. Mellors,et al.  Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART , 2017, Proceedings of the National Academy of Sciences.

[26]  R. Siliciano,et al.  Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. , 2017, Cell host & microbe.

[27]  R. Ribeiro,et al.  HIV persistence in tissue macrophages of humanized myeloid only mice during antiretroviral therapy , 2017, Nature Medicine.

[28]  H. Gendelman,et al.  A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy , 2017, Retrovirology.

[29]  P. Ganz,et al.  Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV , 2016, Journal of the American Heart Association.

[30]  Abraham J. Kandathil,et al.  Are T cells the only HIV-1 reservoir? , 2016, Retrovirology.

[31]  F. Kirchhoff,et al.  HIV Triggers a cGAS-Dependent, Vpu- and Vpr-Regulated Type I Interferon Response in CD4+ T Cells. , 2016, Cell reports.

[32]  R. Dewar,et al.  Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.

[33]  R. Siliciano,et al.  Defective proviruses rapidly accumulate during acute HIV-1 infection , 2016, Nature Medicine.

[34]  B. Walker,et al.  Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. , 2016, Immunity.

[35]  Jonathan L. Schmid-Burgk,et al.  A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2′O-Methylated Self RNA , 2015, Immunity.

[36]  T. Hallett,et al.  Future challenges for clinical care of an ageing population infected with HIV: a modelling study , 2015, The Lancet. Infectious diseases.

[37]  J. Margolick,et al.  Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. , 2015, The Journal of infectious diseases.

[38]  J. Margolick,et al.  The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation , 2015, AIDS.

[39]  D. Hafler,et al.  TLR7 induces anergy in human CD4+ T cells , 2014, Nature Immunology.

[40]  C. Mussini,et al.  Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV. , 2014, Immunology letters.

[41]  Kenneth C. Williams,et al.  The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure , 2014, AIDS.

[42]  G. Hartmann,et al.  Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates , 2014, Nature.

[43]  S. Paludan,et al.  T Cells Detect Intracellular DNA but Fail to Induce Type I IFN Responses: Implications for Restriction of HIV Replication , 2014, PloS one.

[44]  Sharmin Begum,et al.  Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells , 2013, eLife.

[45]  I. Hurbain,et al.  The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. , 2013, Immunity.

[46]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[47]  L. James,et al.  HIV-1 evades innate immune recognition through specific co-factor recruitment , 2013, Nature.

[48]  D. Douek,et al.  Systemic effects of inflammation on health during chronic HIV infection. , 2013, Immunity.

[49]  Nan Yan,et al.  Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses , 2013, Science.

[50]  S. Goodbourn,et al.  LGP2 Plays a Critical Role in Sensitizing mda-5 to Activation by Double-Stranded RNA , 2013, PloS one.

[51]  K. Kraemer,et al.  HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.

[52]  R. Finberg,et al.  Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. , 2013, Immunity.

[53]  K. Conzelmann,et al.  Paramyxovirus V Proteins Disrupt the Fold of the RNA Sensor MDA5 to Inhibit Antiviral Signaling , 2013, Science.

[54]  T. Walz,et al.  Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5 , 2013, Cell.

[55]  Qian Feng,et al.  MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells , 2012, Cell Reports.

[56]  R. Haubrich,et al.  Metabolic Syndrome Before and After Initiation of Antiretroviral Therapy in Treatment-Naive HIV-Infected Individuals , 2012, Journal of acquired immune deficiency syndromes.

[57]  E. Richer,et al.  Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses , 2012, Journal of Cell Science.

[58]  R. Redfield,et al.  Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors , 2012, AIDS.

[59]  J. Margolick,et al.  Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. , 2012, Atherosclerosis.

[60]  N. Grishin,et al.  Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. , 2012, Immunity.

[61]  R. Gorelick,et al.  Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA , 2012, PloS one.

[62]  Bin Wu,et al.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition , 2011, Proceedings of the National Academy of Sciences.

[63]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[64]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[65]  M. Gale,et al.  Immune signaling by RIG-I-like receptors. , 2011, Immunity.

[66]  Jeremy Luban,et al.  TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.

[67]  A. van Dorsselaer,et al.  Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K , 2011, RNA biology.

[68]  M. Wainberg,et al.  RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I , 2010, Journal of Virology.

[69]  D. Levy,et al.  A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells , 2010, Nature.

[70]  R. Sachidanandam,et al.  Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing , 2010, Proceedings of the National Academy of Sciences.

[71]  K. Jeang,et al.  Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs , 2010, Proceedings of the National Academy of Sciences.

[72]  Nicole C. Robb,et al.  RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection , 2010, Cell.

[73]  S. Akira,et al.  Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection , 2009, Journal of Virology.

[74]  J. Hiscott,et al.  RIG-I-like receptors: sensing and responding to RNA virus infection. , 2009, Seminars in immunology.

[75]  A. Schmidt,et al.  5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I , 2009, Proceedings of the National Academy of Sciences.

[76]  Osamu Takeuchi,et al.  Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.

[77]  Kristen K. Dang,et al.  Architecture and Secondary Structure of an Entire HIV-1 RNA Genome , 2009, Nature.

[78]  C. Horvath,et al.  A Shared Interface Mediates Paramyxovirus Interference with Antiviral RNA Helicases MDA5 and LGP2 , 2009, Journal of Virology.

[79]  Mario Roederer,et al.  Emerging concepts in the immunopathogenesis of AIDS. , 2009, Annual review of medicine.

[80]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[81]  S. Goodbourn,et al.  Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins , 2008, Journal of Virology.

[82]  S. Akira,et al.  Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 , 2008, The Journal of experimental medicine.

[83]  S. Goodbourn,et al.  mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. , 2007, Virology.

[84]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[85]  Jeffrey N. Martin,et al.  Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.

[86]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[87]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[88]  J. Darlix,et al.  With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIVMAC , 2006, Gene Therapy.

[89]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[90]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[91]  G. Pavlakis,et al.  RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs , 2006, Retrovirology.

[92]  J. Lifson,et al.  Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. , 2005, The Journal of clinical investigation.

[93]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[94]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[95]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[96]  J. Mascola,et al.  Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells , 2005, Journal of Virology.

[97]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[98]  S. Goodbourn,et al.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[99]  J. Lifson,et al.  Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells , 2004, Journal of Virology.

[100]  J. Dai,et al.  Comparative analysis of IRF and IFN‐alpha expression in human plasmacytoid and monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.

[101]  Jeffrey N. Martin,et al.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.

[102]  T. Rana,et al.  Tat stimulates cotranscriptional capping of HIV mRNA. , 2002, Molecular cell.

[103]  Paul B. Fisher,et al.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Antonio Lanzavecchia,et al.  Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.

[105]  R. Steinman,et al.  Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals1 , 2000, The Journal of Immunology.

[106]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[107]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[108]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[109]  Minoru Yoshida,et al.  CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.

[110]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[111]  J. Sodroski,et al.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[112]  D. Symons,et al.  Collaborative , 2021, Encyclopedia of the UN Sustainable Development Goals.

[113]  V. Kim,et al.  fCLIP-seq for transcriptomic footprinting of dsRNA-binding proteins: Lessons from DROSHA. , 2019, Methods.

[114]  N. Bhardwaj,et al.  Plasmacytoid dendritic cells in HIV infection. , 2013, Advances in experimental medicine and biology.

[115]  Z. Zhai,et al.  VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.

[116]  M. Malim,et al.  The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators. , 1991, Trends in biochemical sciences.